Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients

Sponsor
Khon Kaen Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01547221
Collaborator
(none)
120
1
2
37
3.2

Study Details

Study Description

Brief Summary

Otomycosis is a superficial fungal infection of the external ear canal. Patients should be treated with cleaning fungal debris combined with topical antifungal agent. There is wide range of topical antifungal agents. However, there is still no consensus of the most effective topical antifungal agents in treatment otomycosis is still lacking.

According to Thai National List of essential medicines for topical antifugal agents are:
  • acetic acid (2% in aqueous and 2% in 70% isopropyl alcohol)

  • boric acid (3% in isopropyl alcohol)

  • gentian violet

  • clotrimazole ear drop. But from literature review, there is no comparative study between boric acid and clotrimazole solution before.

Objective is to compare the clinical effectiveness and adverse events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for the treatment of otomycosis.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

The hypothesis has been formulated by H0 and Ha. H0 = 1% clotrimazole solution has clinical effectiveness not different from 3% boric acid in 70% alcohol for the treatment of otomycosis.

Ha = 1% clotrimazole solution has more clinical effectiveness than 3% boric acid in 70% alcohol for the treatment of otomycosis.

Inclusion criteria:
  • Symptomatic otomycosis, age more than 7 year.

  • Microscopic finding revealed fungus

  • KOH smear positive for fungus

Exclusion criteria:
  • Pregnancy

  • Tympanic membrane perforation and post mastoid surgery

  • Co-infection of ear e.g. severe otitis externa,severe myringitis which are needed other medication.

  • Previous using topical antibiotic / steroid within 2weeks.

  • During usage of systemic antifungal drug

  • Allergic to 3% boric acid in 70% alcohol or 1% clotrimazole solution. PICO model: P= otomycosis patient I= 1%clotrimazole ear drop C= 3% boric acid O= result of treatment as cure

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients: a Randomized Controlled Trial
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 3% boric acid

control

Drug: 3% Boric acid
3% boric acid in 70% alcohol was prepared by phamaceutical department of Khonkaen Hospital

Experimental: 1% clotrimazole ear drop

3% boric acid is set as control while 1% clotrimazole ear drop is set as intervention.

Drug: clotrimazole
single application of 1%clotrimazole ear drop
Other Names:
  • Candid
  • Outcome Measures

    Primary Outcome Measures

    1. result as cure rate of otomycosis [1 week after treatment]

      otolaryngologist's microscopic finding

    Secondary Outcome Measures

    1. adverse effect of treatment [Five minutes after apply treatment]

      using questionaire to record adverse effect

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Symptomatic otomycosis, age more than 7 year.

    • Microscopic finding revealed fungus

    • KOH smear positive for fungus

    Exclusion Criteria:
    • Pregnancy

    • Tympanic membrane perforation and post mastoid surgery

    • Co-infection of ear e.g. severe otitis externa, severe myringitis which are needed other medications

    • Previous using topical antibiotic / steroid within 2weeks.

    • During usage of systemic antifungal drug

    • Allergic to 3% boric acid in70% alcohol or 1% clotrimazole solution.

    • Those who can not come to follow up after one week of the treatment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ENT clinic KhonKaen Hospital KhonKaen Thailand 40000

    Sponsors and Collaborators

    • Khon Kaen Hospital

    Investigators

    • Principal Investigator: Sarisa Romsaithong, M.D., Unaffiliate

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ms. Sarisa Romsaithong, Medical physician, senior professional level, Khon Kaen Hospital
    ClinicalTrials.gov Identifier:
    NCT01547221
    Other Study ID Numbers:
    • KKH24-01-2555
    First Posted:
    Mar 7, 2012
    Last Update Posted:
    Apr 28, 2015
    Last Verified:
    Apr 1, 2015
    Keywords provided by Ms. Sarisa Romsaithong, Medical physician, senior professional level, Khon Kaen Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 28, 2015